NO20100097L - Antiviral sammensetning omfattende sulfatert polysakkarid - Google Patents

Antiviral sammensetning omfattende sulfatert polysakkarid

Info

Publication number: NO20100097L
Authority: NO; Norway
Prior art keywords: sulfated polysaccharide; antiviral composition; orthomyxovirus; paramyxovirus; prophylaxis
Prior art date: 2007-08-24

Application number

NO20100097A

Other languages

English (en)

Norwegian (no)

Inventor

Andreas Grassauer

Eva Prieschl-Grassauer

Original Assignee

Marinomed Biotechnologie Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-08-24

Filing date

2010-01-20

Publication date

2010-03-24

2010-01-20 Application filed by Marinomed Biotechnologie Gmbh filed Critical Marinomed Biotechnologie Gmbh

2010-03-24 Publication of NO20100097L publication Critical patent/NO20100097L/no

Links

230000000840 anti-viral effect Effects 0.000 title abstract 3
150000004676 glycans Chemical class 0.000 title 1
229920001282 polysaccharide Polymers 0.000 title 1
239000005017 polysaccharide Substances 0.000 title 1
229920000855 Fucoidan Polymers 0.000 abstract 2
241000700605 Viruses Species 0.000 abstract 2
201000010099 disease Diseases 0.000 abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
208000015181 infectious disease Diseases 0.000 abstract 2
230000001575 pathological effect Effects 0.000 abstract 2
239000008194 pharmaceutical composition Substances 0.000 abstract 2
238000011321 prophylaxis Methods 0.000 abstract 2
230000000241 respiratory effect Effects 0.000 abstract 2
238000011282 treatment Methods 0.000 abstract 2
241000711573 Coronaviridae Species 0.000 abstract 1
ZNOZWUKQPJXOIG-XSBHQQIPSA-L [(2r,3s,4r,5r,6s)-6-[[(1r,3s,4r,5r,8s)-3,4-dihydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]-4-[[(1r,3r,4r,5r,8s)-8-[(2s,3r,4r,5r,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-2-yl]oxy-4-hydroxy-2,6-dioxabicyclo[3.2.1]octan-3-yl]oxy]-5-hydroxy-2-( Chemical compound O[C@@H]1[C@@H](O)[C@@H](OS([O-])(=O)=O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H]2OC[C@H]1O[C@H](O[C@H]1[C@H]([C@@H](CO)O[C@@H](O[C@@H]3[C@@H]4OC[C@H]3O[C@H](O)[C@@H]4O)[C@@H]1O)OS([O-])(=O)=O)[C@@H]2O ZNOZWUKQPJXOIG-XSBHQQIPSA-L 0.000 abstract 1
241000701161 unidentified adenovirus Species 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/731—Carrageenans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Virology (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Communicable Diseases (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Epidemiology (AREA)
Immunology (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Biotechnology (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)

NO20100097A 2007-08-24 2010-01-20 Antiviral sammensetning omfattende sulfatert polysakkarid NO20100097L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US93566807P	2007-08-24	2007-08-24
PCT/EP2008/006910 WO2009027057A1 (fr)	2007-08-24	2008-08-22	Composition antivirale contenant un polysaccharide sulfaté

Publications (1)

Publication Number	Publication Date
NO20100097L true NO20100097L (no)	2010-03-24

Family

ID=40198591

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20100097A NO20100097L (no)	2007-08-24	2010-01-20	Antiviral sammensetning omfattende sulfatert polysakkarid

Country Status (26)

Country	Link
US (2)	US20110059919A1 (fr)
EP (1)	EP2178533B1 (fr)
JP (1)	JP5647518B2 (fr)
KR (1)	KR101571571B1 (fr)
CN (1)	CN101784272B (fr)
AP (1)	AP2630A (fr)
BR (1)	BRPI0815748B8 (fr)
CA (1)	CA2696009C (fr)
CY (1)	CY1113949T1 (fr)
DK (1)	DK2178533T3 (fr)
EA (1)	EA018138B1 (fr)
ES (1)	ES2406684T3 (fr)
HR (1)	HRP20130402T1 (fr)
IL (1)	IL203444A (fr)
MA (1)	MA31748B1 (fr)
MX (1)	MX2010001986A (fr)
MY (1)	MY153900A (fr)
NO (1)	NO20100097L (fr)
NZ (1)	NZ583511A (fr)
PL (1)	PL2178533T3 (fr)
PT (1)	PT2178533E (fr)
SI (1)	SI2178533T1 (fr)
TN (1)	TN2010000086A1 (fr)
UA (1)	UA102673C2 (fr)
WO (1)	WO2009027057A1 (fr)
ZA (1)	ZA201000951B (fr)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9884024B2 (en) *	2005-12-27	2018-02-06	Hemant N Joshi	Physically dispersed, molecularly dissolved and/or chemically bound drug(s) in an empty, hard capsule shell composition
PT2303287E (pt) *	2008-07-01	2014-02-27	Marinomed Biotechnologie Gmbh	Biopolímeros antialérgicos marinhos
WO2010086746A2 (fr) *	2009-01-28	2010-08-05	Life Science Nutrition As	Compositions et méthodes de traitement d'infections virales
JP2010248105A (ja) *	2009-04-14	2010-11-04	Bio Plan:Kk	ウイルス感染阻害用組成物
US20120189706A1 (en) *	2009-10-06	2012-07-26	Knocean Sciences, Inc.	Macrocystis Pyrifera Derived Health and Wellness Products and Methods of Using the Same
SG181421A1 (en) *	2009-12-22	2012-07-30	Marinomed Biotechnologie Gmbh	Synergistic antiviral composition and use thereof
JP2011168533A (ja) *	2010-02-18	2011-09-01	Kyosei Seiyaku Kk	抗インフルエンザウイルス剤
AU2011217746B2 (en) *	2010-02-22	2015-03-05	Marinova Pty Ltd	Anti-viral formulations
CN101869110B (zh) *	2010-07-14	2013-03-13	山东圣鹏农药有限公司	一种抗植物病毒病组合物及其应用
WO2012018628A1 (fr)	2010-07-26	2012-02-09	Board Of Regents, The University Of Texas System	Procédés d'induction d'une réponse immunitaire par l'intermédiaire d'une administration buccale et/ou sublinguale d'un vaccin
FR2969926B1 (fr) *	2011-01-04	2017-03-10	Elicityl	Arabinogalactanes, apiogalacturonanes et heteroglycanes sulfates pour le traitement des maladies causees par les virus influenza
WO2012126777A1 (fr) *	2011-03-18	2012-09-27	Marinomed Biotechnologie Gmbh	Inhibition de l'activité de la neuraminidase
US20130028882A1 (en)	2011-07-07	2013-01-31	Humanitas Technology, LLC	Antiviral compositions and methods of their use
CN102764266A (zh) *	2012-07-30	2012-11-07	吉林省辉南长龙生化药业股份有限公司	褐藻多糖硫酸酯在制备预防和治疗慢性阻塞性肺病药物中的用途
CN102988409A (zh) *	2012-11-26	2013-03-27	合肥博太医药生物技术发展有限公司	硫酸葡聚糖在制备治疗重症肝炎药物中的应用
RU2686088C2 (ru) *	2013-01-25	2019-04-24	Маринова Пти Лтд	Способ обработки экстракта из морских водорослей, экстракт, фармацевтическая композиция, биоматериал, способ лечения, применение экстракта и композиции
US9974850B2 (en)	2013-01-25	2018-05-22	Board Of Regents, The University Of Texas System	Immunogenic compositions and uses thereof
CN103301065A (zh) *	2013-06-27	2013-09-18	辽宁亿灵科创生物医药科技有限公司	一种海藻提取物的鼻喷剂及其制备方法
HUE045990T2 (hu) *	2013-12-03	2020-02-28	Gerolymatos Int S A	Ionos vizes készítmények
ES2734269T3 (es)	2014-01-22	2019-12-05	Visufarma B V	Composición que comprende carragenina tipo iota contra conjuntivitis viral
CN104721221B (zh) *	2015-01-29	2017-08-04	广州暨南生物医药研究开发基地有限公司	琼枝麒麟菜多糖用于制备抗呼吸道病毒药物中的用途
DK3370692T3 (da) *	2015-07-14	2023-06-26	Marinomed Biotech Ag	Sammensætning til frigørelse af tilstoppet næse med antiviral aktivitet
US10434119B2 (en) *	2016-01-13	2019-10-08	Gargle Water, Inc.	Pharyngeal or buccal cavity rinse and process of use thereof
KR102844566B1 (ko)	2016-02-25	2025-08-08	어플라이드 바이올로지컬 래버러토리즈 인코포레이티드	공기 매개 병원체 및 자극물질에 대한 보호용 조성물 및 방법
US12447166B2 (en) *	2016-02-25	2025-10-21	Applied Biological Laboratories, Inc.	Compositions and methods for protecting against airborne pathogens and irritants
CN105748506B (zh) *	2016-03-03	2018-08-17	青岛海洋生物医药研究院股份有限公司	褐藻酸硫酸酯在制备预防和治疗由人乳头瘤状病毒引起的疾病的药物和保健品中的应用
CN106309470B (zh) *	2016-08-30	2021-05-18	闫滨	一种羊栖菜多糖的应用
WO2018144545A1 (fr)	2017-01-31	2018-08-09	Stc.Unm	Compositions polypeptidiques riches en arginine et procédés pour les utiliser
JP7261367B2 (ja) *	2018-02-14	2023-04-20	江南化工株式会社	抗ウイルス剤及び抗ウイルス組成物
JP6942350B2 (ja) *	2018-04-26	2021-09-29	江南化工株式会社	抗ウイルス剤及び抗ウイルス用組成物
US12421626B2 (en)	2018-06-29	2025-09-23	Fred Hutchinson Cancer Center	Cell-stored barcoded deep mutational scanning libraries and uses of the same
US12186334B2 (en) *	2018-07-27	2025-01-07	ARC Medical Inc.	High-molecular-weight fucans for treating fibrous adhesions and other diseases and conditions
KR101995376B1 (ko) *	2018-08-20	2019-07-02	한미약품 주식회사	카라기난을 유효성분으로 포함하는 항-바이러스 조성물
WO2020112088A1 (fr) *	2018-11-27	2020-06-04	Colgate-Palmolive Company	Compositions de soins personnels à multiples bénéfices et leurs procédés
GB2579600B (en)	2018-12-05	2023-07-05	Byotrol Plc	Anti-viral composition
CN112137953A (zh) *	2019-06-26	2020-12-29	山东百骏生物科技有限公司	一种用于感冒辅助治疗的液体敷料
US11821111B2 (en)	2019-11-15	2023-11-21	Fred Hutchinson Cancer Center	Barcoded influenza viruses and deep mutational scanning libraries including the same
WO2021168173A1 (fr) *	2020-02-20	2021-08-26	Synkine Therapeutics, Inc.	Méthodes et compositions pour le traitement d'infections respiratoires virales
CA3171013A1 (fr) *	2020-03-09	2021-09-16	Organes Tissus Regeneration Reparation Remplacement	Composition pour le traitement de lesions du systeme respiratoire
CA3171235A1 (fr) *	2020-03-12	2021-09-16	Sydney David Cullis-Hill	Traitement d'une infection a coronavirus et d'une toxicite liee a cytokine
WO2021191904A1 (fr) *	2020-03-26	2021-09-30	Tree Of Life Pharma Ltd.	Méthodes de prévention et de traitement d'une infection virale
US20230201249A1 (en) *	2020-04-02	2023-06-29	Linhardt Robert John	Compositions incorporating sulfated polysaccharides for inhibiting sars-cov-2
NL2025335B1 (en) *	2020-04-10	2021-10-26	Logick Energetics B V	Pharmaceutical composition for treatment of corona virus infection
CN111471088B (zh) *	2020-04-21	2021-02-09	北京中科微盾生物科技有限责任公司	一种抑制sars-cov-2感染的多肽、组合物及其用途
WO2021253643A1 (fr)	2020-06-18	2021-12-23	大连工业大学	Application de polysaccharides sulfatés contre le nouveau coronavirus
CN111686125A (zh) *	2020-06-18	2020-09-22	大连工业大学	卡拉胶在抗新型冠状病毒中的应用
EP3932412A1 (fr)	2020-06-30	2022-01-05	GSK Consumer Healthcare SARL	Composition pharmaceutique antivirale
EP3932411A1 (fr)	2020-06-30	2022-01-05	GSK Consumer Healthcare SARL	Composition pharmaceutique antivirale
EP3939597A1 (fr) *	2020-07-16	2022-01-19	Marinomed Biotech AG	Composition pharmaceutique antivirale comprenant du carraghénane
CN114053251A (zh) *	2020-07-29	2022-02-18	苏州融析生物科技有限公司	硫酸化多糖吸入制剂及其在防治新冠病毒相关疾病中的应用
US12280142B2 (en)	2020-09-08	2025-04-22	Altamira Medica AG	Compositions for preventing infection
CN112220799A (zh) *	2020-11-02	2021-01-15	江苏泰德医药有限公司	一种抑制病毒的产品及用途
WO2022131283A1 (fr) *	2020-12-15	2022-06-23	正一中村	Aliment et eau potable contenant des algues et leur extrait
WO2022131282A1 (fr) *	2020-12-15	2022-06-23	正一中村	Savon, désinfectant, stérilisateur et détergent contenant des algues et un extrait d'algues
EP4079289A1 (fr)	2021-04-22	2022-10-26	Dutch Renewable Energy B.V.	Composition antivirale pour l'administration dans le nez, la bouche ou la gorge
EP4079300A1 (fr)	2021-04-22	2022-10-26	Dutch Renewable Energy B.V.	Composition anti-virale pour administration dans le nez, la bouche ou la gorge
GB202109888D0 (en)	2021-07-08	2021-08-25	Pollinner Ltd	Nasal spray
EP4130258A1 (fr)	2021-08-02	2023-02-08	Evonik Operations GmbH	Micro-organismes affichant des récepteurs leurres viraux
IL318697A (en) *	2021-08-31	2025-03-01	Polyrizon Ltd	Mucoadhesive polymers for drug release in nasal tissue
CN114264530B (zh) *	2021-12-30	2023-05-05	重庆市畜牧科学院	一种基于Avicel的病毒蚀斑测定方法及其应用
CN114395538A (zh) *	2022-01-19	2022-04-26	和元生物技术（上海）股份有限公司	一种促进重组病毒载体向细胞外分泌的方法
WO2025067689A1 (fr)	2023-09-26	2025-04-03	Metriopharm Ag	5-amino-2,3-dihydro-1,4-phtalazinedione pour le traitement d'infections par un virus à arn

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4783446A (en) *	1985-11-22	1988-11-08	Neushul Mariculture Incorporated	Method for the treatment of AIDS virus and other retroviruses
EP0293826A3 (fr)	1987-06-02	1989-05-10	Stichting REGA V.Z.W.	Application thérapeutique et prophylactique des polysaccharides sulfatés contre le SIDA
CH680265A5 (en) *	1990-06-25	1992-07-31	Madeleine Luescher Mattli Dr	Polyanionic cpds. for treatment of myxo- and para-myxo-virus diseases - effective against e.g. influenza, measles, mumps and distemper and use e.g. a sulphonated polysaccharide
AU1052492A (en) *	1991-01-31	1992-08-06	Farmitalia Carlo Erba S.R.L.	Synergistic composition comprising a fibroblast growth factor and a sulfated polylsaccharide, for use as antiviral agent
EP0678030A1 (fr) *	1993-01-08	1995-10-25	The Population Council	Utilisation de polysaccharides sulfates pour prevenir des maladies sexuellement transmissibles
US5658893A (en) *	1995-03-29	1997-08-19	Abbott Laboratories	Method for inhibition of rotavirus infection with carrageenan
ES2185042T3 (es)	1996-08-12	2003-04-16	Merck & Co Inc	Inhibidores de la trombina.
US6391452B1 (en) *	1997-07-18	2002-05-21	Bayer Corporation	Compositions for nasal drug delivery, methods of making same, and methods of removing residual solvent from pharmaceutical preparations
JPH1180003A (ja) *	1997-09-16	1999-03-23	Yakult Honsha Co Ltd	感染症予防・治療剤
DE19961307A1 (de)	1999-12-18	2001-07-12	Krewel Meuselbach Gmbh	Medizinprodukt zur Befeuchtung und Reinigung der Nasenschleimhaut
JP2001181188A (ja) *	1999-12-28	2001-07-03	Marine Biotechnol Inst Co Ltd	インフルエンザウイルス感染阻害剤
FR2808687B1 (fr)	2000-04-27	2003-12-05	Goemar Lab Sa	Medicament contenant des substances polysaccharidiques pour l'activation de l'apoptose
AU2001268884A1 (en)	2000-06-30	2002-01-14	Polydex Pharmaceuticals Limited	Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections
DE10051955A1 (de) *	2000-10-20	2002-05-02	Wella Ag	Haarbehandlungsmittel in Form eines festen und formstabilen Gels
JP2003081841A (ja)	2001-06-26	2003-03-19	Kikkoman Corp	抗アレルギー体質強化剤
US20030181416A1 (en) *	2002-01-10	2003-09-25	Comper Wayne D.	Antimicrobial charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and method of use thereof
WO2003093322A2 (fr) *	2002-04-30	2003-11-13	The Population Council, Inc.	Formulations ameliorees de polysaccharide sulfate, leurs procedes, preparations et utilisations
KR20050105490A (ko) *	2003-02-26	2005-11-04	오츠카 세이야쿠 가부시키가이샤	경폐 투여용 서방성 제제학적 조성물
WO2005004882A1 (fr)	2003-07-09	2005-01-20	Monash University	Polymeres charges antiviraux presentant une resistance a la degradation lysosomale pendant une filtration renale et un passage renal, compositions et methodes d'utilisation correspondantes
US20080004236A1 (en)	2004-02-06	2008-01-03	Comper Wayne D	High Dose, Short Interval Use of Sulfated Polysaccharides for Treatment of Infections
US20080184618A1 (en) *	2005-08-03	2008-08-07	Amcol International	Virus-Interacting Layered Phyllosilicates and Methods of Use
US20080241271A1 (en) *	2006-11-08	2008-10-02	Roman Stephen B	Foaming anti-adhesion composition

2008
- 2008-08-22 MY MYPI2010000752A patent/MY153900A/en unknown
- 2008-08-22 CN CN200880103946.3A patent/CN101784272B/zh active Active
- 2008-08-22 US US12/673,145 patent/US20110059919A1/en not_active Abandoned
- 2008-08-22 HR HRP20130402AT patent/HRP20130402T1/hr unknown
- 2008-08-22 SI SI200830957T patent/SI2178533T1/sl unknown
- 2008-08-22 BR BRPI0815748A patent/BRPI0815748B8/pt active IP Right Grant
- 2008-08-22 AP AP2010005170A patent/AP2630A/xx active
- 2008-08-22 PT PT87856720T patent/PT2178533E/pt unknown
- 2008-08-22 JP JP2010521363A patent/JP5647518B2/ja active Active
- 2008-08-22 UA UAA201003386A patent/UA102673C2/ru unknown
- 2008-08-22 KR KR1020107002847A patent/KR101571571B1/ko active Active
- 2008-08-22 PL PL08785672T patent/PL2178533T3/pl unknown
- 2008-08-22 EP EP08785672A patent/EP2178533B1/fr active Active
- 2008-08-22 ES ES08785672T patent/ES2406684T3/es active Active
- 2008-08-22 EA EA201070299A patent/EA018138B1/ru not_active IP Right Cessation
- 2008-08-22 NZ NZ583511A patent/NZ583511A/en unknown
- 2008-08-22 MX MX2010001986A patent/MX2010001986A/es active IP Right Grant
- 2008-08-22 CA CA2696009A patent/CA2696009C/fr active Active
- 2008-08-22 DK DK08785672.0T patent/DK2178533T3/da active
- 2008-08-22 WO PCT/EP2008/006910 patent/WO2009027057A1/fr not_active Ceased
2010
- 2010-01-20 NO NO20100097A patent/NO20100097L/no not_active Application Discontinuation
- 2010-01-21 IL IL203444A patent/IL203444A/en active IP Right Grant
- 2010-02-09 ZA ZA2010/00951A patent/ZA201000951B/en unknown
- 2010-02-19 TN TNP2010000086A patent/TN2010000086A1/fr unknown
- 2010-03-19 MA MA32710A patent/MA31748B1/fr unknown
2012
- 2012-05-30 US US13/483,716 patent/US10342820B2/en active Active
2013
- 2013-04-25 CY CY20131100338T patent/CY1113949T1/el unknown

Also Published As

Publication number	Publication date
PL2178533T3 (pl)	2013-08-30
MY153900A (en)	2015-04-15
SI2178533T1 (sl)	2013-07-31
KR20100045468A (ko)	2010-05-03
JP2011512319A (ja)	2011-04-21
EA018138B1 (ru)	2013-05-30
HRP20130402T1 (hr)	2013-06-30
TN2010000086A1 (en)	2011-09-26
HK1144558A1 (en)	2011-02-25
MA31748B1 (fr)	2010-10-01
ES2406684T3 (es)	2013-06-07
KR101571571B1 (ko)	2015-11-24
MX2010001986A (es)	2010-03-11
UA102673C2 (ru)	2013-08-12
PT2178533E (pt)	2013-06-03
CN101784272B (zh)	2014-03-12
BRPI0815748B1 (pt)	2019-04-24
CA2696009A1 (fr)	2009-03-05
EP2178533A1 (fr)	2010-04-28
EP2178533B1 (fr)	2013-03-27
ZA201000951B (en)	2011-04-28
AP2010005170A0 (en)	2010-02-28
US10342820B2 (en)	2019-07-09
CA2696009C (fr)	2016-08-02
WO2009027057A1 (fr)	2009-03-05
NZ583511A (en)	2012-02-24
DK2178533T3 (da)	2013-05-27
US20120237572A1 (en)	2012-09-20
BRPI0815748A2 (pt)	2015-02-18
IL203444A (en)	2015-05-31
BRPI0815748B8 (pt)	2021-05-25
AU2008291290A1 (en)	2009-03-05
EA201070299A1 (ru)	2010-08-30
US20110059919A1 (en)	2011-03-10
CN101784272A (zh)	2010-07-21
CY1113949T1 (el)	2016-07-27
AP2630A (en)	2013-03-28
JP5647518B2 (ja)	2014-12-24

Publication	Publication Date	Title
NO20100097L (no)	2010-03-24	Antiviral sammensetning omfattende sulfatert polysakkarid
CL2012000147A1 (es)	2012-09-07	Compuestos derivados del acido 5-etinil-3(formilamino) tiofeno-2-carboxilico, inhibidores de los virus de la familia flaviviridae; composicion farmaceutica que comprende un compuesto; y su uso de los compuestos en la preparacion de medicamentos.
CY1119216T1 (el)	2018-02-14	Φαρμακευτικη συνθεση για εισπνοη
NO2019026I1 (no)	2019-06-13	Kombinasjon av glykopyrrolat (inkludert eventuelle farmasøytisk akseptable salter, estere eller enantiomerer derav) og formoterol (innbefattende hvilke som helst farmasøytisk akseptable salter, estere eller enantiomerer derav)
BRPI0814899A2 (pt)	2015-02-03	Composição, vacina, metodo para amenizar um ou mais sintomas associados à infecção com o virus da influenza em um individuo e método para reduzir a probabilidade de infecção com o virus da influeza em um individuo"
WO2011000566A3 (fr)	2011-05-26	Composés et compositions pharmaceutiques pour le traitement de d'infections virales à arn simple brin, sens négatif
UA108072C2 (uk)	2015-03-25	Засіб для профілактики і лікування високопатогенних інфекційних захворювань
UY33620A (es)	2012-04-30	Análogos de azido nucleósidos y nucleótidos
NO20083562L (no)	2008-10-20	Cannabinoidreseptormodulatorer
ECSP11011310A (es)	2011-10-31	Análogos carba - nucleósido para tratamiento antiviral
CL2013001715A1 (es)	2013-12-20	Compuestos derivados de indol, inhibidores de la replicacion del rsv; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento de la infeccion por el virus sincicial respiratorio.
CO6362026A2 (es)	2012-01-20	Derivado de ácido halurónico polisulfatado de bajo peso molecular y un medicamento que lo contiene
CL2012001959A1 (es)	2012-12-07	Compuestos derivados del acido tiofeno-2-carboxilico, inhibidores de virus flaviviridae; composicion farmaceutica que los comprende; y su uso para el tratamiento de una infeccion viral por flaviviridae.
NO20082047L (no)	2008-04-29	Sakte frigivende sammensetning, fremgangsmate for fremstilling derav og anvendelse av samme
EA201290373A1 (ru)	2012-11-30	Синергическая противовирусная композиция и ее применение
BR112015030140A2 (pt)	2017-07-25	forma de dosagem farmacêutica sólida para liberação de pelo menos um ingrediente farmacêutico ativo na cavidade oral
TN2009000275A1 (en)	2010-10-18	Use of substituted pyranone acid derivatives for the treatment of metabolic syndrome
WO2013026558A3 (fr)	2013-04-11	Agent de polythérapie
BR112015010842A8 (pt)	2019-10-01	uso da ciclesonida para o tratamento de doença das vias respiratórias em cavalos
NO20092763L (no)	2009-07-27	Isosorbid mononitrat derivater for behandling av tarmlidelser
BRPI0706871A2 (pt)	2016-08-09	uso de um extrato de sambucus nigra l., método de tratamento de uma infecção viral de influenza e método de inibição da infecção viral de influenza
ITMI20060158U1 (it)	2007-11-05	Apparecchiatura per la somministrazione di ossigeno o di aria addizionata da ossigeno,per terapie respiratorie.
UA100883C2 (ru)	2013-02-11	Применение дронедарона для получения лекарственного средства для лечения пациентов с аритмией и с повышенным уровнем креатинина в результате введения дронедарона
CL2014001046A1 (es)	2014-11-14	Proceso de preparacion de compuestos derivados de acilguanidinas y aciltioureas, utiles para el tratamiento de enfermedades de los pulmones y de las vias respiratorias; y compuestos intermediarios utilizados en dicho proceso.
NO20060229L (no)	2006-01-16	Gaboxadol for behandling av depresjon og andre affektive lidelser

Legal Events

Date	Code	Title	Description
2014-03-24	FC2A	Withdrawal, rejection or dismissal of laid open patent application